184 related articles for article (PubMed ID: 37770911)
1. Assessment of the diagnostic accuracy of Vibrasense compared to a biothesiometer and nerve conduction study for screening diabetic peripheral neuropathy.
Sharma K N S; Kumar H A
J Foot Ankle Res; 2023 Sep; 16(1):65. PubMed ID: 37770911
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study.
Santos TRM; Melo JV; Leite NC; Salles GF; Cardoso CRL
J Diabetes Complications; 2018 Aug; 32(8):770-776. PubMed ID: 29950276
[TBL] [Abstract][Full Text] [Related]
3. Quantitative vibration perception threshold in assessing diabetic polyneuropathy: Should the cut-off value be adjusted for Chinese individuals with type 2 diabetes?
Liu M; Gao Y; Chen DW; Lin S; Wang C; Chen LH; Ran XW
J Diabetes Investig; 2021 Sep; 12(9):1663-1670. PubMed ID: 33512757
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the neurothesiometer and biothesiometer for measuring vibration perception in diabetic patients.
Young MJ; Every N; Boulton AJ
Diabetes Res Clin Pract; 1993 May; 20(2):129-31. PubMed ID: 8375265
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Glycated Hemoglobin and Vibration Perception Threshold in Diabetic Peripheral Neuropathy.
Maiya AG; Parameshwar A; Hande M; Nandalike V
Int J Low Extrem Wounds; 2020 Jun; 19(2):120-124. PubMed ID: 31838926
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of clinical tools and their diagnostic use in distal symmetric polyneuropathy.
Pourhamidi K; Dahlin LB; Englund E; Rolandsson O
Prim Care Diabetes; 2014 Apr; 8(1):77-84. PubMed ID: 23664849
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the new indicator test for sudomotor function (Neuropad) with the vibration perception threshold and the clinical examination in the diagnosis of peripheral neuropathy in subjects with type 2 diabetes.
Papanas N; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Maltezos E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):135-8. PubMed ID: 18095233
[TBL] [Abstract][Full Text] [Related]
8. Comparing the Ipswich Touch Test (IpTT) and 10gm-SMWF (10-gm Semmes-Weinstein mono-filament) in Indian population subset with type 2 diabetes mellitus to detect diabetes neuropathy.
Senthilkumar S; Dasarathan R; Pazhani P; Gaur A; Sakthivadivel V
Ir J Med Sci; 2023 Dec; 192(6):2793-2799. PubMed ID: 37140765
[TBL] [Abstract][Full Text] [Related]
9. The use of biothesiometry to detect neuropathy in children and adolescents with IDDM.
Davis EA; Jones TW; Walsh P; Byrne GC
Diabetes Care; 1997 Sep; 20(9):1448-53. PubMed ID: 9283795
[TBL] [Abstract][Full Text] [Related]
10. [Vibration perception threshold in diagnosing diabetic peripheral neuropathy by receiver operating characteristic curve].
Hou Y; Liu S; Zhu T; Zhang H; Liu G; Zhu Y; Chen H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Sep; 37(9):951-6. PubMed ID: 23000772
[TBL] [Abstract][Full Text] [Related]
11. Validation of Neuropad in the Assessment of Peripheral Diabetic Neuropathy in Patients with Diabetes Mellitus Versus the Michigan Neuropathy Screening Instrument, 10g Monofilament Application and Biothesiometer Measurement.
Zografou I; Iliadis F; Sambanis C; Didangelos T
Curr Vasc Pharmacol; 2020; 18(5):517-522. PubMed ID: 31340739
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic.
Olaleye D; Perkins BA; Bril V
Diabetes Res Clin Pract; 2001 Nov; 54(2):115-28. PubMed ID: 11640995
[TBL] [Abstract][Full Text] [Related]
13. Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy.
Goel A; Shivaprasad C; Kolly A; Sarathi H A V; Atluri S
PLoS One; 2017; 12(9):e0183973. PubMed ID: 28880907
[TBL] [Abstract][Full Text] [Related]
14. Relevance of ankle reflex as a screening test for diabetic peripheral neuropathy.
Malik MM; Jindal S; Bansal S; Saxena V; Shukla US
Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S340-1. PubMed ID: 24251208
[TBL] [Abstract][Full Text] [Related]
15. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.
Magri CJ; Calleja N; Buhagiar G; Fava S; Vassallo J
Postgrad Med J; 2011 Oct; 87(1032):658-63. PubMed ID: 21954032
[TBL] [Abstract][Full Text] [Related]
16. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study.
Martin CL; Waberski BH; Pop-Busui R; Cleary PA; Catton S; Albers JW; Feldman EL; Herman WH;
Diabetes Care; 2010 Dec; 33(12):2635-41. PubMed ID: 20833868
[TBL] [Abstract][Full Text] [Related]
17. Comparison of vibration perception thresholds obtained with the Neurothesiometer and the CASE IV and relationship to nerve conduction studies.
Bril V; Perkins BA
Diabet Med; 2002 Aug; 19(8):661-6. PubMed ID: 12147147
[TBL] [Abstract][Full Text] [Related]
18. Abnormal vibration perception threshold alters the gait features in type 2 diabetes mellitus patients.
Dong L; Hu Y; Xu L; Zeng H; Shen W; Esser P; Dawes H; Liu F
Front Endocrinol (Lausanne); 2022; 13():1092764. PubMed ID: 36844372
[TBL] [Abstract][Full Text] [Related]
19. Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability.
van Deursen RW; Sanchez MM; Derr JA; Becker MB; Ulbrecht JS; Cavanagh PR
Diabet Med; 2001 Jun; 18(6):469-75. PubMed ID: 11472466
[TBL] [Abstract][Full Text] [Related]
20. Validation of bedside methods in evaluation of diabetic peripheral neuropathy.
Jayaprakash P; Bhansali A; Bhansali S; Dutta P; Anantharaman R; Shanmugasundar G; Ravikiran M
Indian J Med Res; 2011 Jun; 133(6):645-9. PubMed ID: 21727664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
